Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Coplanar Capital, LLC is an independent asset manager based in Atlanta, Georgia, founded in 2019. The firm specializes in 'Double-Result investing,' which aims to achieve financial returns while addressing social and environmental challenges. This approach allows Coplanar to support founders who are developing transformational solutions to global issues.
The firm currently manages a portfolio of 8 companies and focuses on early-stage investments, particularly in the Bio+Health ecosystem. Coplanar Capital emphasizes the importance of exceptional teams pursuing large markets with transformative technologies. The organization is led by a team with over 60 years of combined venture capital experience, which enhances their ability to identify and nurture impactful ventures.
Coplanar Capital has established itself as a multi-fund impact manager, with notable funds including the Black Men's Health Fund, which emphasizes health and diversity, and the Dunamis Clean Tech Fund, focusing on clean technology. Their commitment to social responsibility is reflected in their investment strategy and the companies they choose to support.
Coplanar Capital invests primarily in the Bio+Health ecosystem, targeting diverse businesses and services that align with their mission of 'Double-Result investing.' The firm focuses on early-stage investments, specifically in pre-seed, Series A, and Series B rounds. They prefer minority equity positions, allowing them to support founders while minimizing risk.
The investment strategy emphasizes backing exceptional teams that are pursuing large markets with transformative technologies. Coplanar Capital seeks to partner with startups that not only aim for financial success but also strive to create positive social and environmental impacts. This dual focus on financial returns and societal benefits distinguishes Coplanar from traditional venture capital firms.
Coplanar Capital's portfolio includes 8 notable companies, each contributing to advancements in the Bio+Health sector:
Dr. Quentin J. Florence - Chief Investment Officer: Dr. Florence has extensive experience in venture capital and a strong background in the Bio+Health sector. He has led numerous successful investments and is known for his expertise in identifying high-impact ventures.
Doug Vander Linde - President: As a founding partner, Vander Linde brings expertise in competitive analysis and operational excellence. He has a proven track record in the biotech and health sectors, focusing on nurturing ventures that align with Coplanar's mission.
To pitch Coplanar Capital, founders should use the contact form available on their website. It is important to include a comprehensive deck that outlines the business model, market opportunity, and the social and environmental impact of the startup.
While specific response times are not disclosed, founders should expect a thorough review process. Warm introductions are preferred, as they can facilitate a more favorable evaluation of the pitch.
As of April 2023, Coplanar Capital continues to expand its portfolio within the Bio+Health sector, focusing on companies that align with their 'Double-Result investing' philosophy. The firm has not publicly announced any recent exits or new fund raises, but their commitment to impactful investing remains strong.
In 2022, Coplanar Capital launched the Black Men's Health Fund, emphasizing health equity and diversity in healthcare solutions. This fund aims to support startups that address health disparities in underserved communities.
What are Coplanar Capital's investment criteria?
Coplanar Capital focuses on early-stage investments in the Bio+Health sector, specifically targeting pre-seed to Series B rounds. They prefer to take minority equity positions and look for exceptional teams pursuing large markets with transformative technologies.
How can I apply or pitch to Coplanar Capital?
Founders can pitch their ideas through the contact form available on the Coplanar Capital website. It is advisable to include a detailed business plan and highlight the social and environmental impact of the proposed solution.
What makes Coplanar Capital different from other venture capital firms?
Coplanar Capital's unique approach is centered around 'Double-Result investing,' which aims to achieve both financial returns and positive social and environmental impacts. This dual focus sets them apart from traditional venture capital firms that primarily prioritize financial gains.
What is Coplanar Capital's geographic scope?
The firm primarily invests in startups located in the United States, focusing on the Bio+Health ecosystem.
What kind of post-investment involvement does Coplanar Capital have?
Coplanar Capital actively supports its portfolio companies by leveraging its team's extensive venture capital experience and expertise in transformative technologies. This involvement often includes mentorship and operational support.
What is the typical check size for investments made by Coplanar Capital?
While specific check sizes are not disclosed, Coplanar Capital typically invests in early-stage rounds, which can range from pre-seed to Series B funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.